~~<i id='FCF8B4213F'><strike id='FCF8B4213F'><tt id='FCF8B4213F'><pre id='FCF8B4213F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

focus

author：leisure time 2025-10-03 00:04:30 - browse：64

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： ProMED, early warning system on disease outbreaks, in peril

Wikipedia

explore

leisure time

Wikipedia

knowledge

TedW.Love,sittingintheplaidshirt,withhisfamilyin1964CourtesyTedLoveIwasborninAlabamaintheJimCrowSout

WSS

OTC birth control: A brief history of over the counter pill design

Medicare slashes safety net hospital payments by nearly $1 billion

Dramatically reducing cancer deaths requires the PASTEUR Act

Flint parents haunted by uncertainty, fears of lead poisoning

Nearly two

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Wikipedia

focus

Wikipedia

Virginia high school admissions case could be legal follow

Late stage cancers on the rise after pandemic delayed screenings

DIEP, the 'gold standard' of breast reconstruction, is under threat

What Mike Pence has said that could be used in a Donald Trump trial

Dobbs anniversary: the lost opportunity of abortion as health care

Influencer to be charged after chaos erupts in New York City's Union Square

Moonlake's readout produced a cash windfall. Risks remain

Late stage cancers on the rise after pandemic delayed screenings

United colonoscopy coverage change 'may cost lives,' doctors say

Humana, CVS hope to turn members into patients at clinics

explore

OTC birth control: A brief history of over the counter pill design

Medicare slashes safety net hospital payments by nearly $1 billion

Late stage cancers on the rise after pandemic delayed screenings

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

H.R. 3 is the wrong path to lower drug costs

Alnylam reports growth in sales of rare disease treatments

leisure time

Wikipedia

Wikipedia

knowledge